GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » Enterprise Value

Corix Bioscience (Corix Bioscience) Enterprise Value : $0.00 Mil (As of May. 22, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Corix Bioscience's Enterprise Value is $0.00 Mil. Corix Bioscience's EBIT for the trailing twelve months (TTM) ended in Sep. 2017 was $-4.94 Mil. Therefore, Corix Bioscience's EV-to-EBIT ratio for today is 0.00.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Corix Bioscience's Enterprise Value is $0.00 Mil. Corix Bioscience's EBITDA for the trailing twelve months (TTM) ended in Sep. 2017 was $-4.78 Mil. Therefore, Corix Bioscience's EV-to-EBITDA ratio for today is 0.00.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Corix Bioscience's Enterprise Value is $0.00 Mil. Corix Bioscience's Revenue for the trailing twelve months (TTM) ended in Sep. 2017 was $0.00 Mil. Therefore, Corix Bioscience's EV-to-Revenue ratio for today is .


Corix Bioscience Enterprise Value Historical Data

The historical data trend for Corix Bioscience's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience Enterprise Value Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
Enterprise Value
Get a 7-Day Free Trial - 2.33 0.47 464.28 15.86

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.90 15.86 6.48 19.11 23.03

Competitive Comparison of Corix Bioscience's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corix Bioscience's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's Enterprise Value falls into.



Corix Bioscience Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Corix Bioscience's Enterprise Value for the fiscal year that ended in Dec. 2016 is calculated as

Corix Bioscience's Enterprise Value for the quarter that ended in Sep. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Corix Bioscience  (GREY:CXBS) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Corix Bioscience's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/-4.941
=0.00

Corix Bioscience's current Enterprise Value is $0.00 Mil.
Corix Bioscience's EBIT for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.94 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Corix Bioscience's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=0.000/-4.781
=0.00

Corix Bioscience's current Enterprise Value is $0.00 Mil.
Corix Bioscience's EBITDA for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.78 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Corix Bioscience's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.000/0
=

Corix Bioscience's current Enterprise Value is $0.00 Mil.
Corix Bioscience's Revenue for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Corix Bioscience Enterprise Value Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Corix Bioscience (Corix Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines